Jazz Pharmaceuticals PLC (JAZZ) valuation history

$214.00

Latest weekly close · Market cap $14.9B

Share JAZZ P/S history
Historically high

As of

JAZZ's P/S of 3.2x is higher than 91% of its weekly readings over the last five years.

Weekly P/S with its 5-year range

P/S each weekMiddle half of the last 5 years5-year median 2.5×
P/S weekly history1×2×3×4×5×3.2×20222023202420252026
5-year median
2.5×
10-year median
3.1×
5-year low to high
1.5×–3.9×
Versus 5-year median
+29%

P/S

91stpercentile

of its weekly readings over the last five years

Historically high

Growth, last 12 months vs the year before

Revenue
+13%accelerating
EPS
n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
-1,00001,0002,00020222023202420252026

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

JAZZ P/S at each year-end
Year-endP/S5-year percentile
2.6×54
1.9×5
2.3×3
2.8×13
2.7×3
4.1×28
4.1×9
4.3×1
5.2×7
4.7×2

Loading peers and related research…

About this history

What is JAZZ's current P/S?
JAZZ's P/S of 3.2x is higher than 91% of its weekly readings over the last five years.
What is JAZZ's five-year median P/S?
2.5x. Half of JAZZ's weekly readings over the last five years were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares JAZZ only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built